Page last updated: 2024-08-17

trifluridine and Hematologic Diseases

trifluridine has been researched along with Hematologic Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abbruzzese, JL; Fukushima, M; Hoff, P; Kopetz, S; Kuwata, K; Mita, A; Overman, MJ; Varadhachary, G; Wolff, RA; Xiong, H	1

Trials

1 trial(s) available for trifluridine and Hematologic Diseases

Article	Year
Phase I clinical study of three times a day oral administration of TAS-102 in patients with solid tumors. Cancer investigation, 2008, Volume: 26, Issue:8 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Pyrrolidines; Thymine; Trifluridine; Uracil	2008

Article

Year

Phase I clinical study of three times a day oral administration of TAS-102 in patients with solid tumors.

Cancer investigation, 2008, Volume: 26, Issue:8

Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Pyrrolidines; Thymine; Trifluridine; Uracil

2008